Cannabis has long been at the center of medical and scientific debates, especially regarding its component substances – cannabidiol (CBD) and tetrahydrocannabinol (THC).
The psychoactive component of cannabis, THC, is known for both its benefits and drawbacks, and researchers continue to seek ways to enhance its therapeutic effects while minimizing unwanted side effects.
A breakthrough from researchers at the University of Mississippi may offer new possibilities. They have discovered how CBD, a non-psychoactive compound in cannabis, interacts with the same receptors as THC.
This discovery could lead to improved pain management treatments and new ways to mitigate THC’s negative effects, such as memory loss and nausea.
New perspective on CBD
Amar Chittiboyina, principal scientist and associate director of the National…